Job Opportunities API

Remix Therapeutics is a clinical-stage biopharmaceutical company pioneering a new class of medicines that modulate RNA splicing to address the underlying biology of disease. Our lead program, REM-422, targets pre-mRNA splicing in oncology and  represents  a fundamentally differentiated approach to drug discovery. Headquartered in Watertown, MA, Remix is advancing its pipeline with the urgency and scientific rigor that patients deserve.   Position Summary: Remix is seeking an exceptional Vice President of Quality to serve as the architect and guardian of our quality organization at a pivotal moment in our growth. Reporting to the Chief Operating Officer, this leader will define the global quality vision and build the systems, culture, and capabilities required to advance REM-422 from clinical development through potential commercialization.   This is a rare opportunity to build a world-class quality function from the ground up within a science-driven organization where quality is understood as a patient safety imperative — not a compliance afterthought. The VP of Quality will bring deep expertise across GxP disciplines, a risk-based mindset, and the leadership presence to inspire confidence across internal teams, external partners, and Health Authorities alike.   Key Responsibilities: Quality Vision & Strategy   Define and drive the Quality vision, objectives, and culture of Remix, establishing quality as a strategic enabler of the company's mission   Design, develop, and oversee a risk-based, phase-appropriate Quality Management System (QMS) spanning pre-clinical through commercialization   Ensure the QMS meets FDA, EMA, and ICH standards while remaining agile and fit-for-purpose for a clinical-stage organization   Build and lead Remix's quality organization from the ground up; hire and develop a small, high-impact team while establishing the infrastructure, processes, and culture to scale alongside the pipeline   GxP Compliance & Health Authority Engagement   Lead Health Authority inspections (FDA, EMA, and other applicable agencies) and all inspection readiness activities across GxP disciplines   Serve as primary quality point of contact in regulatory interactions and submissions; ensure quality sections of INDs, NDAs/BLAs, MAAs, and other submissions meet agency expectations   Maintain a comprehensive inspection readiness program ensuring the organization is always in a state of audit readiness   Monitor evolving regulatory requirements, ICH guidance, and industry best practices; assess impact and implement appropriate updates to the QMS   GCP & Clinical Quality   Provide GCP quality oversight across all clinical development programs, including protocol development, site qualification, monitoring, and data integrity   Partner with Drug Safety/Pharmacovigilance to provide quality oversight of PV activities, including SAE reconciliation, SUSAR reporting, PBRER/DSUR quality review, and inspection readiness for safety databases and processes   Ensure pharmacovigilance quality agreements and audit programs are in place with CROs and technology vendors supporting safety data collection and reporting   Collaborate closely with Clinical Operations, Biostatistics, and Regulatory Affairs to ensure clinical data quality standards are embedded throughout trial execution   GMP & CMC Quality   Oversee quality aspects of small molecule drug substance and drug product manufacturing, including batch review and product release at Contract Manufacturing Organizations (CMOs)   Establish and maintain robust supplier qualification, oversight, and performance management program